Safety and efficacy of anti-biofilm and anti-inflammatory covered biliary metal stent
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0002310
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 26
1. Only adults over 19 years old
2. A patient required biliary drainage with a malignant biliary obstruction
3. A patient with distal malignant biliary obstruction located below 2 cm lower part to the hepatic hilum.
4. Patients who are unable to perform surgery or who are unable to perform due to systemic or comorbid conditions
5. A person who understands in this clinical trial and agrees to participate and has agreed in writing with the subject or legal representative.
1. Under 18 years old
2. Patients with suspected benign biliary strictures
3. If the life expectancy is less than 1 month due to multiple systemic metastasis
4. Patients who can not understand or agree with this study
5. Patients with uncontrolled bleeding and bleeding tendencies.
6. Patients who have difficulty in endoscopic procedures due to anatomic deformity by existing surgery.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method stent patency
- Secondary Outcome Measures
Name Time Method The detection rate of silver ion in serum and urine;stent related adverse event